UK needs a national arthroplasty register
This article was originally published in Clinica
Executive Summary
The debate continues on the need for a national arthroplasty register in the UK. Surgeons are finding it increasingly difficult to select prostheses since clinical testing in the UK prior to the launch of an implant is not necessary. A national arthroplasty register would provide an unbiased scientific evaluation of any total joint replacement, but would involve a lot of work, according to a letter in the BMJ (July 13th). Correct use of resources and services should lead to higher efficiency and improved clinical practice. Follow-up would include clinical and survival studies and assessment of patient satisfaction.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.